Glaukos files patent lawsuit against Ivantis

Glaucoma treatment company Glaukos Corporation said it filed a patent infringement lawsuit against Ivantis, Inc. in the US District Court for the Central District of California, Southern Division.

“The lawsuit alleges that Ivantis’ Hydrus Microstent device infringes Glaukos patents relating to certain of Glaukos’ core glaucoma technologies,” said Glaukos.

Glaukos CEO Thomas Burns said: “Since our founding in 1998, Glaukos has invested considerable time and resources to develop novel technologies that create entirely new treatment options for glaucoma surgeons and their patients.

“This lawsuit reflects our unwavering commitment to protect our proprietary inventions for the benefit of patients, customers, shareholders, employees and others who rely on us.”